IQVIA Holdings | IQV - Gross Profit On Sales


IQVIA Holdings reported $1.07B in Gross Profit on Sales for its fiscal quarter ending in March of 2026.





Gross Profit On Sales Change Date
Accenture USD 6.13B 674.97M Mar/2026
Agilent USD 990M 44M Mar/2026
Bruker USD 379.8M 69.4M Mar/2026
Cardinal Health USD 2.5B 101M Mar/2026
Celltrion KRW 46.98B 579.12B Dec/2025
Charles River Laboratories USD 279.32M 7.36M Mar/2026
Cigna USD 6.08B 50.37B Mar/2026
Cognizant Technology Solutions USD 1.63B 25M Mar/2026
Computer Programs Systems USD 35.62M 3.23M Dec/2025
Cspc Pharmaceutical CNY 4.01B 329.18M Dec/2025
CVS Health USD 15.62B 2.06B Mar/2026
Danaher USD 3.59B 375M Mar/2026
Dentsply International USD 427M 16M Mar/2026
Deva Holding AS TRY 1.32B 235.77M Sep/2023
Dianthus Therapeutics USD 284K 112K Dec/2025
Divis Laboratories Ltd INR 16.59B 2.05B Dec/2025
Elevance Health USD 11.68B 889M Dec/2025
Humana USD 4.82B 754M Jun/2025
IBM USD 9.19B 2.74B Mar/2026
Illumina USD 721M 38M Mar/2026
Infosys INR 143.44B 15.17B Mar/2026
Kangmei Pharma CNY 238.34M 31.95M Mar/2026
Knight Therapeutics CAD 64.72M 8.91M Dec/2025
Laboratorios Farma EUR 105.28M 177.08M Jun/2025
Laboratory Of America USD 1.01B 20.6M Mar/2026
McKesson USD 3.68B 143M Dec/2025
Mettler Toledo International USD 675.44M 65.98M Dec/2025
Organigram Holdings CAD 23.32M 8.52M Dec/2025
Pharma Mar EUR 39.24M 47.46M Mar/2026
Publicis EUR 1.86B 235.5M Jun/2025
Qiagen NV USD 325.27M 19.53M Dec/2025
Quest Diagnostics USD 906M 33M Mar/2026
Revvity USD 387.66M 34M Mar/2026
Sartorius EUR 414.5M 18.3M Mar/2026
Sino Biopharmaceutical CNY 10.5B 2.53B Dec/2024
Thermo Fisher Scientific USD 4.49B 146M Mar/2026
Tilray USD 57.47M 10.16M Jun/2025
UnitedHealth USD 18.49B 2.14B Dec/2025
Veeva Systems USD 678.61M 56.14M Mar/2026
Veradigm USD 83.44M 3.95M Sep/2022
Waters USD 542M 15.42M Mar/2026
Zealand Pharma A/S 68.91M 19.35M Dec/2025
Zz Pientze Pharmaceu CNY 1.16B 860.2M Mar/2026